Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 9, 2008 11:22:58 AM CDT

Learn about Newser Points »

Back to the grid

FDA May Ban Cold Medicines for Young Children

Posted Sep 29, 07 8:35 AM CDT in Business,  Science & Health    Editor's Choice

(Newser) – FDA experts have concluded that over-the-counter cough and cold medicines are not safe  for very young children, and they're urging the agency to ban them. In a safety review released yesterday, they conclude that the medicines are not proven effective in children under 6 and have been implicated in more than 100 deaths. Most of the deaths were children under 2, and many were thought to be due to overdoses.

The action would affect some 800 medicines targeted to kids with names like Toddler's Dimetapp, Triminic Infant, and Little Colds. Doctors have requested that the FDA pull "infant" formulations from the market and standardize the droppers and cups sold with products for children to reduce the risk of overdoes. A set of outside experts will meet later this month to offer recommendations to the FDA, the New York Times reports.

Source New York Times

Editor Recommended

Related News

  • FDA Orders Urgent Warning About Cipro

    Jul 8, 08 3:09 PM CDT
    FDA Orders Urgent Warning About Cipro The FDA today mandated urgent “black box” warning labels on Cipro and other antibiotics of the powerful flouroquinolone family of drugs. The antibiotics carry a risk of tendinitis and tendon rupture, which could leave patients severely disabled, the AP reports. Particularly vulnerable are those over 60 and patients who have undergone heart, lung, or kidney transplants. More »

  • Popular Cancer Drug Is Iffy and Expensive

    Jul 6, 08 10:48 AM CDT
    Popular Cancer Drug Is Iffy and Expensive Avastin is one of the most widely prescribed cancer drugs in the world, but it might not work, the New York Times reports. The drug, made by Genentech, brings in about $2.3 billion a year in the US alone, but recent trials have shown that though the drug shrinks tumors in sufferers of colon, breast, and lung cancer, it offers little extension of life. More »

  • FDA Salmonella Probe Switches to Jalapenos

    Jul 5, 08 5:37 AM CDT
    FDA Salmonella Probe Switches to Jalapenos Jalapeno peppers have pushed tomatoes off the top of the FDA's suspect list in the recent salmonella outbreak, reports the Wall Street Journal. Investigators believe salsa may be the culprit in the rash of illnesses, and after a drop in tomato consumption failed to halt a rise in cases, they switched focus to other ingredients—especially peppers. The agency says tomatoes aren't in the clear yet, but the hunt is on for tainted jalapenos. More »

  • You Say Tomato, the FDA Says There's Another Culprit Here

    Jul 2, 08 3:13 PM CDT
    You Say Tomato, the FDA Says There's Another Culprit Here Health officials are looking into produce other than tomatoes as the source of the recent salmonella outbreak, reports the Los Angeles Times. With much of the tomato harvest wrapped up and new cases emerging, the FDA is investigating produce typically served with tomatoes, though officials refuse to say what that other produce might be. More »

  • 8 Meds Docs Won't Take

    Jun 23, 08 7:55 PM CDT
    8 Meds Docs Won't Take Some drugs have such serious drawbacks that even doctors won’t take them, Men’s Health reports. The big eight:

    • Advair: Can actually increase the severity of asthma attacks
    • Avandia: Diabetes drug carries risk of heart attack
    More »

FDA Cautions Against Cold Medicine For Young Kids   (Getty Images (by Event))
Teen Use Of Cold Medicine As A Recreational Drug On The Rise   (Getty Images)
prev    next
play

Threads (1 of 1)

Tags

FDA  • prescription drugs


Loading...

Loading...

Related Thread: Pharma Misbehaving

Next story from this section »

Today's Most Popular


Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »